Pascal Breton serves as the Chief Executive Officer of VitamFero SA and was the President of VitamFero SA since January 2009. His interest includes biotechnology, R&D, business development, drug development, pharma/clinical development, drug discovery and formulation and vaccines. He has also worked as the Global Key Account Manager at SGS Life Science Services (Belgium), Director Business Development at IDM Pharma (France and USA), Director R&D at Halisol (France) and Project Leader at UPSA (a French BMS subsidiary). He holds a PhD from University of Orléans (France) in 1989. Pascal Breton serves as the Chief Executive Officer of VitamFero SA and was the President of VitamFero SA since January 2009. His interest includes biotechnology, R&D, business development, drug development, pharma/clinical development, drug discovery and formulation and vaccines. He has also worked as the Global Key Account Manager at SGS Life Science Services (Belgium), Director Business Development at IDM Pharma (France and USA), Director R&D at Halisol (France) and Project Leader at UPSA (a French BMS subsidiary). He holds a PhD from University of Orléans (France) in 1989.

virology, vaccination and veterinary sciences